FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VALSTAR (valrubicin) from Endo USA, Inc., potentially expanding or updating its labeling for use in bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma in Situ of the Urinary Bladder

Drugs mentioned

• VALSTAR (valrubicin)

Snippet

SUPPL AP for VALSTAR (VALRUBICIN)